Composition comprising a UV-screening agent, fatty compounds and a spherical silica

Abstract

Composition comprising a UV-screening agent, fatty compounds and a spherical silica The invention relates to a cosmetic or dermatological composition comprising a UV- screening agent, dicaprylyl carbonate, diisopropyl adipate, diisopropyl sebacate and a spherical amorphous silica.

Description

[0001] Description

[0002] Title: Composition comprising a UV-screening agent, fatty compounds and a spherical silica

[0003] Technical field

[0004] The present invention relates to a composition, notably a cosmetic or dermatological composition, in particular for caring for and / or protecting keratin materials, notably for caring for and / or protecting the skin, comprising a UV-screening agent, fatty compounds and a spherical silica.

[0005] Prior art

[0006] It is known that radiation with a wavelength of between 280 nm and 400 nm enables tanning of the human epidermis and that radiation with a wavelength of between 280 and 320 nm, known under the name UVB rays, harms the development of a natural tan. Exposure is also liable to induce impairment of the biomechanical properties of the epidermis, which is reflected by the appearance of wrinkles, leading to premature aging of the skin.

[0007] It is also known that UVA rays with a wavelength of between 320 and 400 nm penetrate more deeply into the skin than UVB rays. UVA rays bring about immediate and persistent tanning of the skin. Daily exposure to UVA rays, even of short duration, under normal conditions can result in damage to the collagen fibers and the elastin, which is reflected by a modification of the microrelief of the skin, the appearance of wrinkles and uneven pigmentation (liver spots, nonuniformity of the complexion).

[0008] Protection against UVA and UVB radiation is thus necessary. An effective photoprotective product must protect against both UVA and UVB radiation.

[0009] Many photoprotective compositions have been proposed to date to overcome the effects induced by UVA and / or UVB radiation. They generally contain UV-screening agents which function according to their own chemical nature and according to their own properties by absorption, reflection or scattering of the UV radiation, such as for example mixtures of liposoluble organic UV-screening agents and / or water-soluble organic UV-screening agents. Thus, there is a constant demand for sun protection means for controlling natural tanning, with a view to controlling the color of the skin, and for means for maintaining the natural elasticity of the skin.For this purpose, use is generally made of photoprotective compositions comprising UVA-active and / or UVB-active organic screening agents, the degree of UV protection offered by a photoprotective composition is directly related to the amount and types of UV-screening agents that it contains. The higher the amount of UV-screening agents, the greater the degree of UV protection. In particular, the photoprotective compositions must provide good protection against the sun, a measure of which is the sun protection factor (SPF) value. There is also consumer demand for sun protection products that provide a pleasant sensory perception. Indeed, sun protection compositions are often very tacky and leave a film on keratin materials that is uncomfortable for the user.

[0010] It currently remains difficult to obtain compositions that can be spread homogeneously, that are effective in protecting keratin materials, and provide a pleasant sensory perception, in particular a non-tacky feeling, while remaining stable. In particular, these compositions must be sufficiently adherent to the skin in order to confer effective protection without imparting an unpleasant feeling.

[0011] Thus, it remains particularly difficult to obtain photoprotective compositions that meet all the consumer requirements.

[0012] Disclosure of the invention

[0013] In light of the foregoing, there thus remains a need for a sun protection composition which is stable, in particular for 2 months at 4°C, room temperature (25°C) and 45°C, which spreads well over the entire surface of the skin, leaving a homogeneous and adherent film, without leaving a tacky feeling.

[0014] The invention is specifically directed toward meeting these needs.

[0015] Summary of the invention

[0016] The inventors have discovered, surprisingly, that the combination of dicaprylyl carbonate, diisopropyl adipate, diisopropyl sebacate and spherical silica particles in the presence of UV-screening agents makes it possible to obtain a stable composition, with no tacky sensation after application to the skin. The composition spreads easily on the skin and forms a homogeneous and adherent film.Thus, according to a first aspect, the present invention relates to a composition, preferably a cosmetic or dermatological composition, in particular for caring for keratin materials, preferably for caring for the skin, comprising:

[0017] - a UV-screening agent;

[0018] - dicaprylyl carbonate;

[0019] - diisopropyl adipate;

[0020] - diisopropyl sebacate; and

[0021] - a spherical amorphous silica.

[0022] The invention also relates to a non-therapeutic cosmetic process for caring for keratin materials, in particular the skin, comprising the application to the keratin materials, in particular the topical application to these keratin materials, of a composition as defined previously.

[0023] The present invention also relates to the non-therapeutic use of a composition as described previously in the cosmetic field, for caring for keratin materials, in particular the skin of the face and / or the body, to protect keratin materials, in particular the skin, when exposed to UV radiation.

[0024] Other features, aspects and advantages of the invention will become apparent on reading the detailed description that is to follow.

[0025] Detailed description

[0026] According to a particular embodiment of the invention, the composition according to the invention is a cosmetic or dermatological composition.

[0027] The composition according to the invention is non-therapeutic.

[0028] The composition according to the invention is generally suitable for topical application to the skin and thus generally comprises a physiologically acceptable medium, i.e. a medium that is compatible with the skin.

[0029] The term "cosmetic or dermatological” refers to a composition that is compatible with the skin, mucous membranes and skin appendages.

[0030] The term "keratin materials” in particular means the skin, mucous membranes, fibers, eyelashes and skin appendages.The term “the skin” means all the skin of the body, and preferably the skin of the face, the scalp, the neckline, the neck, the arms and forearms, the eyelids, around the mouth or behind the ears, the hollow of the elbow, the back of the knees, the hands, the wrists and the ankles, or even more preferably the skin of the face (in particular the forehead, the nose, the cheeks and the chin), the neckline and the neck.

[0031] In the context of the present invention, the terms “prevent” and “prevention” denote the reduction to a lesser degree of the risk or probability of occurrence of a given phenomenon.

[0032] UV-screening agents

[0033] As mentioned above, the composition according to the invention comprises at least one UV-screening agent. A UV-screening agent is understood to mean a compound which substantially reduces ultraviolet radiation.

[0034] The UV-screening agents used can be organic or inorganic. The organic UV-screening agents used may be lipophilic, hydrophilic or water-dispersible.

[0035] A “lipophilic organic screening agent” is understood to mean any cosmetic organic compound for screening out UV radiation, which can be fully dissolved in the molecular state in a liquid fatty phase or else which can be solubilized in colloidal form (for example in micellar form) in a liquid fatty phase.

[0036] A “hydrophilic organic screening agent” is understood to mean any cosmetic organic compound for screening out UV radiation, which can be fully dissolved in molecular form in a liquid aqueous phase or dissolved in colloidal form (for example in micellar form) in a liquid aqueous phase.

[0037] The term “water-dispersible organic screening agent” means any organic screening agent that is capable of forming, in a liquid aqueous phase, a homogeneous suspension of particles with a volume-average size of less than 100 microns. The volume-average size is determined by laser diffraction particle size analysis.

[0038] The UV-screening agent(s) present in a composition according to the invention are chosen from UV-screening agents that are active in the UVA and / or UVB range.

[0039] According to a preferred embodiment, the UV-screening agent(s) are chosen from organic UV-screening agents, preferably from lipophilic organic UV-screening agents and / or hydrophilic organic UV-screening agents.Lipophilic organic UV-screening age n is

[0040] The lipophilic organic screening agent(s) are chosen in particular from cinnamic compounds; anthranilate compounds; salicylic compounds; dibenzoylmethane compounds; benzylidenecamphor compounds; benzophenone compounds; P,P-diphenylacrylate compounds; triazine compounds; benzotriazole compounds; benzalmalonate compounds, in particular those cited in patent US 5624663; benzimidazole compounds; imidazoline compounds; merocyanine compounds; bis-benzazolyl compounds, such as described in patents EP 669323 and US 2,463,264; methylenebis(hydroxyphenylbenzotriazole) compounds, such as described in applications US 5,237,071, US 5,166,355, GB 2303549, DE 197 26 184 and EP 893119; benzoxazole compounds, such as described in patent applications EP 0832642, EP 1027883, EP1300137 and DE 10162844; screening polymers and screening silicones, such as those described in particular in application WO-93 / 04665; dimers derived from a-alkyl styrene, such as those described in patent application DE 19855649; 4,4-diarylbutadiene compounds, such as described in applications EP 0967200, DE 19746654, DE 19755649, EP-A-1008586, EP 1133980 and EP 133981, and mixtures thereof.

[0041] As examples of lipophilic organic photoprotective agents, mention may be made of those denoted hereinbelow under their INCI name and / or their chemical name.

[0042] Cinnamic compounds:

[0043] - Ethylhexyl Methoxycinnamate notably sold under the trade name Parsol® MCX by the company DSM Nutritional Products;

[0044] - Isoamyl p-Methoxy cinnamate, sold under the trade name Neo Heliopan E 1000® by the company Symrise.

[0045] Dibenzoylmethane compounds:

[0046] Butyl Methoxy dibenzoylmethane notably sold under the trade name Parsol® 1789 by the company DSM Nutritional Products.

[0047] Salicylic compounds:

[0048] - Homosalate sold under the name Parsol® HMS by the company DSM Nutritional Products; - Ethylhexyl Salicylate sold under the name Neo Heliopan® OS by the company Symrise.

[0049] B,B-Diphenylacrylate compounds:

[0050] Octocrylene, notably sold under the trade name Uvinul® N 539 T by the company BASF.Benzophenone compounds:

[0051] - Benzophenone-3 or Oxybenzone, sold under the trade name Uvinul® M 40 by the company BASF,

[0052] - Diethylamino hydroxybenzoyl hexyl benzoate, sold under the trade name Uvinul® A Plus or, as a mixture with ethylhexyl methoxy cinnamate, under the trade name Uvinul® A Plus B by the company BASF.

[0053] Benzylidene camphor compounds:

[0054] 4-Methylbenzylidene camphor, sold under the name Eusolex® 6300 by the company Merck.

[0055] Phenylbenzotriazole compounds:

[0056] Drometrizole Trisiloxane manufactured under the name Mexoryl® XL by the company Noveal.

[0057] Methylenebislhydroxyphenylbenzotri azole) compounds:

[0058] Methylene bis-Benzotriazolyl Tetramethylbutylphenol notably in solid form, such as the product sold under the trade name Mixxim BB / 100® by the company Fairmount Chemical.

[0059] Triazine compounds:

[0060] - 3,3’-(l,4-Phenylene)bis(5,6-diphenyl-l,2,4-triazine), having the INCI name Phenylene Bis-Diphenyl Triazine,

[0061] - Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine sold under the trade name Tinosorb® S by the company BASF,

[0062] - Ethylhexyl Triazone, notably sold under the trade name Uvinul® T 150 by the company BASF,

[0063] - Diethylhexyl Butamido Triazone sold under the trade name Uvasorb® HEB by the company 3V Sigma,

[0064] - symmetrical triazine screening agents substituted with naphthalenyl groups or polyphenyl groups described in patent US 6,225,467, patent application WO 2004 / 085412 (see compounds 6 and 9) or the document “Symmetrical Triazine Derivatives” IP.COM IPCOM000031257 Journal, Inc West Henrietta, NY, US (September 20, 2004).

[0065] Anthranilic compounds:

[0066] Menthyl anthranilate sold under the trade name Neo Heliopan® MA by Symrise.

[0067] Benzalmalonate compounds:

[0068] Polyorganosiloxane bearing benzalmalonate functions, such as Polysilicone-15, sold under the trade name Parsol SLX® by the company Hoffmann-La Roche.Merocyanine compounds:

[0069] Methoxypropylamino cyclohexenylidene ethoxy ethylcyanoacetate (INCI name), and the 2E geometric isomers thereof.

[0070] According to a preferred embodiment, the lipophilic organic UV-screening agent(s) are chosen from dibenzoylmethane compounds, benzophenone compounds, phenylbenzotriazole compounds, triazine compounds, merocyanine compounds and mixtures thereof.

[0071] The lipophilic organic UV-screening agent(s) may be present in a content ranging from 5% to 30% by weight, in particular from 10% to 25% by weight, and preferably from 15% to 20% by weight relative to the total weight of the composition.

[0072] Hydrophilic organic UV-screening agents

[0073] Among the water-soluble organic UVA screening agents that can be used according to the present invention, mention may be made of benzene-l,4-bis(3-methylidene-10-camphorsulfonic) acid (INCI name: Terephthalylidene Dicamphor Sulfonic Acid) and the various salts thereof, notably described in patent applications FR-A-2528420 and FR-A-2639347. Mention may notably be made of benzene-l,4-bis(3-methylidene-10-camphorsulfonic) acid (INCI name: Terephthalylidene Dicamphor Sulfonic Acid) such as the product which is manufactured under the name Mexoryl® SX by the company Noveal. These screening agents correspond to the general formula (I) below:

[0074] [Chem 1]

[0075] 0

[0076]

[0077] in which F denotes a hydrogen atom, an alkali metal or a radical NH(RI)3+in which the radicals R which may be identical or different, denote a hydrogen atom, a C1-C4 alkyl or hydroxyalkyl radical or a group Mn+, Mn+denoting a polyvalent metal cation in which n is equal to 2 or 3 or 4, Mn+preferably denoting a metal cation chosen from Ca2+, Zn2+, Mg2+, Ba2+, Al3+and Zr4+. It is clearly understood that the compounds of formula (I) above cangive rise to the “cis-trans” isomer around one or more double bonds and that all the isomers fall within the context of the present invention.

[0078] Among the water-soluble organic UVA-screening agents that may be used according to the present invention, mention may also be made of compounds including at least two benzazolyl groups bearing sulfonic groups, such as those described in patent application EP-A-0669323.

[0079] They are described and prepared according to the syntheses indicated in patent US 2 463 264 and also in patent application EP-A-0669323.

[0080] The compounds including at least two benzazolyl groups in accordance with the invention correspond to the general formula (II) below:

[0081] [Chem 2]

[0082]

[0083] in which,

[0084] - Z represents an organic residue of valency (1 + n) comprising one or more double bonds placed such that it or they complete(s) the system of double bonds of at least two benzazolyl groups as defined inside the square brackets so as to form a totally conjugated assembly; - X’ denotes S, O or NR6;

[0085] - R1denotes a hydrogen atom, a Ci to Ci8alkyl, a Ci to C4alkoxy, a C5to Ci5aryl, a C2to Cis acyloxy, or a group SO3Y or COOY;

[0086] - the radicals R2, R3, R4and R5, which may be identical or different, denote a nitro group or a radical R1;

[0087] - R6denotes a hydrogen atom, a Ci to C4alkyl or a Ci to C4hydroxy alkyl;

[0088] - Y denotes a hydrogen atom, Li, Na, K, NH4, l / 2Ca, l / 2Mg, 1 / 3A1 or a cation resulting from the neutralization of a free acid group with an organonitrogen base;

[0089] - m is 0 or 1;

[0090] - n is a number from 2 to 6;

[0091] - l is a number from 1 to 4;

[0092] - with the proviso that 1 + n does not exceed the value 6.Among these compounds, preference will most particularly be given to 1,4-bis(benzimidazolyl)phenylene-3,3’,5,5’-tetrasulfonic acid (INCI name: Disodium Phenyl Dibenzimidazole Tetrasulfonate) or a salt thereof, having the following structure, notably sold under the name Neo Heliopan® AP by the company Symrise:

[0093] [Chem 3]

[0094]

[0095] Preferably, the water-soluble screening agent that is capable of absorbing UVA rays is benzene-l,4-bis(3-methylidene-10-camphorsulfonic) acid (INCI name: Terephthalylidene Dicamphor Sulfonic Acid) such as the product which is manufactured under the name Mexoryl SX by Noveal.

[0096] The water-soluble organic UVB-screening agents that can be used according to the present invention are notably chosen from water-soluble cinnamic compounds, such as ferulic acid or 3 -methoxy-4-hydroxy cinnamic acid; water-soluble benzylidenecamphor compounds; water-soluble phenylbenzimidazole compounds; water-soluble p-aminobenzoic (PABA) compounds; water-soluble salicylic compounds, and mixtures thereof.

[0097] As examples of water-soluble organic UVB-screening agents, mention may be made of phenylbenzimidazole compounds, such as 2-phenyl-lH-benzimidazole-5-sulfonic acid (INCI name: phenylbenzimidazole sulfonic acid) notably sold under the trade name Eusolex 232® by Merck.

[0098] The composition according to the invention may also comprise at least one mixed water-soluble screening agent that is capable of absorbing UVA and UVB rays.

[0099] When the water-soluble UV-screening agent is of sulfonic acid type, it is preferably associated with an organic base, such as an alkanolamine.

[0100] The term “alkanolamine” means a C2-Ci0compound comprising at least one primary, secondary or tertiary amine function and at least one alcohol, generally primary alcohol, function. As suitable alkanolamines, mention may be made of 2-amino-2-(hydroxymethyl)-1,3 -propanediol (INCI name: Tromethamine) and triethanolamine.The hydrophilic organic UV-screening agent(s) may be present in a content ranging from 0.01% to 5% by weight, in particular from 0.1% to 3% by weight, relative to the total weight of the composition.

[0101] Water-dispersible organic UV-screening agents

[0102] Benzophenone compounds:

[0103] 1 , 1’ -( 1 ,4-piperazinediyl)bis[ 1 -[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]methanone] (CAS 919803-06-8), as described in patent application WO 2007 / 071584; this compound advantageously being used in micronized form (volume-average size of 0.02 to 2 pm), which may be obtained, for example, according to the micronization process described in patent applications GB-A-2 303 549 and EP-A-893119, and notably in the form of an aqueous dispersion.

[0104] Methylenebis(hydroxyphenylbenzotriazole) compounds:

[0105] Methylenebis(benzotriazolyl)tetramethylbutylphenol in the form of an aqueous dispersion of micronized particles with a volume-average particle size which ranges from 0.01 to 5 pm, and more preferentially from 0.01 to 2 pm and more particularly from 0.020 to 2 pm, with at least one alkyl polyglycoside surfactant having the structure CnH2n+iO(C6Hio05)xH, in which n is an integer from 8 to 16 and x is the mean degree of polymerization of the (C6HI0O5) unit and ranges from 1.4 to 1.6 such as the aqueous dispersions described in patent GB-A-2303 549, in particular the product sold under the trade name Tinosorb® M by BASF, or in the form of an aqueous dispersion of micronized particles with a volume-average particle size which ranges from 0.02 to 2 pm, and more preferentially from 0.01 to 1.5 pm and more particularly from 0.02 to 1 pm, in the presence of at least one polyglyceryl mono(C8-C2o)alkyl ester with a degree of glycerol polymerization of at least 5, such as the aqueous dispersions described in patent application WO 2009 / 063392, in particular the product sold under the name Tinosorb WPGL by BASF.

[0106] Triazine compounds:

[0107] - bis(ethylhexyloxyphenol)methoxyphenyl triazine in its water-dispersible form, having the INCI name Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (and) Acrylates / C12-22 Alkyl Methacrylate Copolymer, under the trade name Tinosorb® S LiteAquaby the company BASF,

[0108] - symmetrical triazine screening agents substituted with naphthalenyl groups or polyphenylgroups used in micronized form (average particle size of 0.02 to 3 pm) which may be obtained, for example, via the micronization process described in patent applications GB-A-2 303 549 and EP-A-893119, and notably in aqueous dispersion form, notably 2,4,6-tris(biphenyl)triazine and 2,4,6-tris(terphenyl)triazine sold under the name Tinosorb® A2B by the company BASF and included in patent applications WO 06 / 035000, WO 06 / 034982, WO 06 / 034991, WO 06 / 035007, WO 2006 / 034992 and WO 2006 / 034985.

[0109] Benzoxazole compounds:

[0110] 2-[4-(l,3-benzoxazol-2-yl)phenyl]-l,3-benzoxazole, having the CAS number 904-39-2.

[0111] According to a preferred embodiment of the invention, the water-dispersible organic UV-screening agent(s) may be present in a content of less than 3% by weight, in particular less than 2% by weight, preferably less than 1% by weight, preferentially less than 0.5% by weight relative to the total weight of the composition, and more preferentially, the composition is free of water-dispersible organic UV-screening agent.

[0112] Inorganic UV-screening agents

[0113] According to a particular embodiment of the invention, the compositions comprise at least one inorganic UV-screening agent.

[0114] The inorganic UV-screening agents that may be used are metal oxide pigments. More preferentially, the inorganic UV-screening agents of the invention are metal oxide particles having an average elementary particle size of less than or equal to 0.5 pm, more preferentially of between 0.005 and 0.5 pm, and more preferentially still of between 0.01 and 0.2 pm, even better still between 0.01 and 0.1 pm, and more particularly between 0.015 and 0.05 pm. They are notably described in Annex VI, updated on 22 / 09 / 2021, of the European regulation on cosmetic products number 1223 / 2009, but are not limited to that list. They may in particular be selected from titanium, zinc, iron, zirconium and cerium oxides, or mixtures thereof.

[0115] Such coated or uncoated metal oxide pigments are described in particular in patent application EP-A-0 518 773. Commercial pigments that may be mentioned include the products sold by the companies Croda, Tayca and Merck.

[0116] The metal oxide pigments may be coated or uncoated.The coated pigments are pigments that have undergone one or more surface treatments of chemical, electronic, mechanochemical and / or mechanical nature with compounds such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithins, sodium, potassium, zinc, iron or aluminum salts of fatty acids, metal alkoxides (of titanium or aluminum), polyethylene, silicones, proteins (collagen, elastin), alkanolamines, silicon oxides, metal oxides or sodium hexametaphosphate.

[0117] The coated pigments are more particularly titanium oxides that have been coated:

[0118] - with hydrated silica, such as the product MT-100WP from the company Tayca,

[0119] - with silica and iron oxide, such as the product Sunveil F® from the company Ikeda, - with silica and alumina, such as the products MT-500SA® and MT-100 SA® from the company Tayca, and Tioveil™ AQ-N from the company Croda,

[0120] - with alumina, such as the product TTO-55 (A)® from the company Ishihara,

[0121] - with alumina and aluminum stearate, such as the products MT 100 TV®, MT 100 Z® and MT-01® from the company Tayca, the product Solaveil™ CT100 from the company Croda and the product Eusolex T-AVO® from the company Merck,

[0122] - with silica, alumina and alginic acid, such as the product MT-100 AQ® from the company Tayca,

[0123] - with alumina and aluminum laurate,

[0124] - with iron oxide and iron stearate,

[0125] - with zinc oxide and zinc stearate,

[0126] - with silica and alumina and treated with a silicone, such as the products MTY-500SAS® or Microtitanium Dioxide MT-100 SAS® from the company Tayca,

[0127] - with silica, alumina, aluminum stearate and treated with a silicone,

[0128] - with silica and treated with a silicone,

[0129] - with alumina and treated with a silicone, such as the product TTO-55(S)® from the company Ishihara,

[0130] - with triethanolamine,

[0131] - with stearic acid, such as the product TTO-55 (C)® from the company Ishihara,

[0132] - with sodium hexametaphosphate,

[0133] - TiO2treated with octyltrimethylsilane,

[0134] - TiO2treated with a polydimethylsiloxane,

[0135] - anatase / rutile TiO2treated with a polydimethylhydrosiloxane,- TiO2coated with triethylhexanoin, with aluminum stearate and with alumina sold under the trade name Solaveil™ CT-200 by Croda,

[0136] - TiO2coated with aluminum stearate, with alumina and with silicone sold under the trade name Solaveil™ CT-12W-by Croda,

[0137] - TiO2coated with lauroyl lysine,

[0138] - TiO2coated with C9-C15 fluoroalcohol phosphate and aluminum hydroxide.

[0139] Mention may also be made of TiO2pigments doped with at least one transition metal such as iron, zinc or manganese and more particularly manganese. Preferably, said doped pigments are in the form of an oily dispersion. The oil present in the oily dispersion is preferably chosen from triglycerides including those of capric / caprylic acids. The oily dispersion of titanium oxide particles may also include one or more dispersants, for instance a sorbitan ester, for instance sorbitan isostearate, or a polyoxyalkylenated fatty acid ester of glycerol, for instance TRI-PPG-3 myristyl ether citrate and polyglyceryl-3 polyricinoleate. Preferably, the oily dispersion of titanium oxide particles includes at least one dispersant chosen from polyoxyalkylenated fatty acid esters of glycerol. Mention may be made more particularly of the oily dispersion of TiO2particles doped with manganese in capric / caprylic acid triglyceride in the presence of TRI-PPG-3 myristyl ether citrate and polyglyceryl-3 polyricinoleate and sorbitan isostearate having the INCI name: titanium dioxide (and) TRI-PPG-3 myristyl ether citrate (and) polyglyceryl-3 ricinoleate (and) sorbitan isostearate, or the product sold under the trade name Optisol™ OTP-1 by the company Croda.

[0140] Uncoated titanium oxide pigments are sold, for example, by the company Tayca under the trade names MT-500B and MT-600B®, or by the company Evonik under the trade name DegussaP 25.

[0141] The uncoated zinc oxide pigments are, for example:

[0142] - those sold under the name Z-Cote® by BASF;

[0143] - those sold under the name NanoArc® Zinc Oxide by the company Nanophase Technologies.

[0144] The coated zinc oxide pigments are, for example:

[0145] - ZnO coated with polymethylhydrosiloxane;

[0146] - Solaveil™ CZ-100 from Croda, dispersed in Ci2-Ci5alkyl benzoate (INCE Zinc Oxide (and) C 12-15 Alkyl Benzoate (and) Polyhydroxystearic Acid (and) Isostearic Acid);

[0147] - those sold under the name Daitopersion Zn-60VA® by the company Daito Kasei(dispersions in C9-Ci2alkane with a dispersant);

[0148] - those sold under the name SPD-Z5® by the company Shin-Etsu (ZnO coated with silicone-grafted acrylic polymer, dispersed in cyclodimethylsiloxane).

[0149] The uncoated cerium oxide pigments may be, for example, those sold under the name Rhodigard® W185 by the company Solvay.

[0150] Mention may also be made of mixtures of metal oxides, in particular of titanium dioxide and of cerium dioxide, including the equal-weight mixture of titanium dioxide and cerium dioxide coated with silica, and also the mixture of titanium dioxide and zinc dioxide coated with alumina, silica and silicone or coated with alumina, silica and glycerol.

[0151] When the composition comprises one or some inorganic UV-screening agents, coated or uncoated titanium oxide pigments are particularly preferred.

[0152] According to a preferred embodiment of the invention, the inorganic screening agent(s) may be present in a content of less than 2% by weight, in particular less than 1% by weight, preferably less than 0.5% by weight relative to the total weight of the composition, and preferentially, the composition is free of inorganic screening agents.

[0153] According to a preferred embodiment, the UV-screening agent(s) are chosen from lipophilic organic UV-screening agents and / or hydrophilic organic UV-screening agents, in particular from dibenzoylmethane compounds, benzophenone compounds, phenylbenzotriazole compounds, triazine compounds, merocyanine compounds, benzene- l,4-di(3-m ethylidene-10-camphorsulfonic) acid and mixtures thereof, and preferably from butyl methoxydibenzoylmethane, diethylamino hydroxybenzoyl hexyl benzoate, drometrizole trisiloxane, bis-ethylhexyloxyphenol methoxyphenyl triazine, ethylhexyl triazone, methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate (INCI name), and also the ZZE geometric isomers thereof, benzene- l,4-di(3-methylidene-10-camphorsulfonic) acid and mixtures thereof.

[0154] According to a particular embodiment, the composition in accordance with the invention is devoid of ethylhexyl methoxycinnamate (octinoxate), and / or devoid of octocrylene, and / or devoid of ethylhexyl salicylate, and preferably, the composition in accordance with the invention does not contain ethylhexyl methoxycinnamate or octocrylene or ethylhexyl salicylate.The UV-screening agent(s) may be present in a content ranging from 5% to 35% by weight, preferably from 7% to 30% by weight, and more preferentially from 10% to 25% by weight relative to the total weight of the composition.

[0155] Fatty compounds

[0156] The composition according to the invention comprises a specific fatty substance mixture consisting of dicaprylyl carbonate, diisopropyl adipate and diisopropyl sebacate.

[0157] The dicaprylyl carbonate may be present in a content ranging from 2% to 8% by weight, preferably from 4% to 6% by weight, relative to the total weight of the composition.

[0158] The diisopropyl adipate may be present in a content ranging from 2% to 7% by weight, preferably from 3% to 5% by weight, relative to the total weight of the composition.

[0159] The diisopropyl sebacate may be present in a content ranging from 2% to 8% by weight, preferably from 4% to 6% by weight, relative to the total weight of the composition.

[0160] The dicaprylyl carbonate, diisopropyl adipate and diisopropyl sebacate may be present in a total content ranging from 6% to 25%, preferably from 10% to 20% and better still from 12% to 15% by weight relative to the total weight of the composition.

[0161] According to a particular embodiment, the composition may comprise an additional oil chosen in particular from isopropyl myristate, isopropyl palmitate, isononyl isononanoate, alkyl benzoates having between 12 and 15 carbon atoms, caprylic / capric triglycerides, ethylhexyl hydroxystearate, and mixtures thereof.

[0162] The additional oil may be present in a content ranging from 1% to 15% by weight and preferably from 2% to 10% by weight relative to the total weight of the composition.

[0163] According to a preferred embodiment, the composition comprises isopropyl myristate, in particular in a content ranging from 1% to 10% by weight, preferably ranging from 2% to 5% by weight, relative to the total weight of the composition.

[0164] According to a preferred embodiment, the composition comprises alkyl benzoates having between 12 and 15 carbon atoms, in particular in a content ranging from 0.5% to 5% by weight, preferably ranging from 1% to 3% by weight relative to the total weight of the composition.According to a preferred embodiment of the invention, the composition comprises dicaprylyl carbonate, diisopropyl adipate, diisopropyl sebacate, isopropyl myristate and alkyl benzoates having between 12 and 15 carbon atoms.

[0165] Spherical silica

[0166] The composition according to the invention comprises spherical amorphous silica particles. According to certain embodiments, the mean size of these spherical amorphous silica particles is less than 15.0 pm and more particularly between 3 and 10 pm.

[0167] As examples of spherical amorphous silicas, mention may be made of the porous silica microspheres sold under the name Silica Beads SB-700 by the company Myoshi (mean size 4.6 pm and oil absorption capacity Wp: 133 ml / 100 g); Sunsphere® H51 (mean size 5.1 pm and oil absorption capacity Wp: 133 ml / 100 g), Sunsphere® H33 (mean size 2.9 pm and oil absorption capacity Wp: 370 ml / 100 g) by the company Asahi Glass.

[0168] The spherical amorphous silica may be present in a content ranging from 1% to 10% by weight, preferably ranging from 2% to 8% by weight, and more preferentially ranging from 3% to 7% by weight relative to the total weight of the composition.

[0169] According to a particular embodiment, a composition according to the invention comprises at least:

[0170] - from 5% to 35% by weight, preferably from 7% to 30% by weight, relative to its total weight, of UV-screening agent(s), in particular of lipophilic and / or hydrophilic organic UV-screening agent(s), preferably chosen from dibenzoylmethane compounds, benzophenone compounds, phenylbenzotriazole compounds, triazine compounds, cyano compounds, benzene- 1,4-di (3 -methylidene- 10-camphorsulfonic) acid and mixtures thereof;

[0171] - from 6% to 25% by weight, preferably from 10% to 20% by weight, relative to its total weight, of dicaprylyl carbonate, diisopropyl adipate and diisopropyl sebacate taken together; and

[0172] - from 1% to 10% by weight, in particular from 2% to 8% by weight, relative to its total weight, of spherical amorphous silica.

[0173] Lipophilic polymerThe composition according to the invention may comprise a lipophilic polymer comprising monomer units of formulae (A) and (B):

[0174] [Chem 4]

[0175] [Chem 5]

[0176]

[0177] in which:

[0178] Rbindependently of one another, are chosen from alkyl or alkylene radicals;

[0179] with at least 60% by weight of the Ri groups being behenyl radicals, the weight percentage relating to the sum of all the Ri groups present in the polymer; the weight ratio of the sum of all the hydroxy ethyl acrylate units to the sum of all the acrylate units bearing the Ri group ranges from 1 :30 to 1:1; and the sum of the total of units A and B is at least 95% by weight of the total weight of the polymer.

[0180] Preferably, Ri consists of alkyl radicals, preferably of Ci6-C22 alkyl radicals, and more preferentially of behenyl (C22) radicals.

[0181] Preferably, at least 70% by weight of the Ri groups are behenyl radicals, preferentially at least 80% by weight, and more preferentially at least 90% by weight relative to the sum of all the Ri groups present in the polymer.

[0182] According to one preferred embodiment, all the Ri groups are behenyl radicals.

[0183] Preferably, said weight ratio ranges from 1:15 to 1:1 and preferentially ranges from 1:10 to 1:4. Advantageously, the polymer units present in the polymer consist of the units (A) and (B) previously described.

[0184] The polymer has a number-average molecular weight Mn ranging from 2000 to 9000 g / mol, preferably ranging from 5000 to 9000 g / mol. The number-average molecular weight can bemeasured by the gel permeation chromatography method, for example according to the method described in the example hereinbelow.

[0185] Preferably, the polymer has a melting point ranging from 60°C to 69°C and preferentially ranging from 63°C to 67°C. The melting point is measured by differential scanning calorimetry (DSC), for example according to the method described in the example hereinbelow.

[0186] The polymer used according to the invention may be prepared by polymerization of a monomer of formula CH2=CH-COO-RI, Ri having the meaning described previously, and of 2 -hydroxy ethyl acrylate.

[0187] The polymerization may be performed according to known methods, such as solution polymerization or emulsion polymerization.

[0188] The polymerization is, for example, described in document US 2007 / 0264204.

[0189] The lipophilic polymer may be present in the composition in a content ranging from 0.5% to 6% by weight, preferably from 1% to 4% by weight, relative to the total weight of the composition.

[0190] Crosslinked polymer containing acrylic units and C10-C30 alkyl acrylate units The composition according to the invention may comprise a crosslinked polymer containing acrylic units and Cio-C3oalkyl acrylate units.

[0191] A crosslinked polymer containing acrylic units and C10-C30 alkyl acrylate units, which can be used in the context of the present invention, is intended to denote more particularly a terpolymer of a mixture of monomers essentially comprising:

[0192] (a) an acrylic, methacrylic or ethacrylic acid, but preferably acrylic or methacrylic acid, (b) an acrylate of formula:

[0193] [Chem 6]

[0194] CH2: c - — c: — OB2

[0195] I II

[0196]

[0197] R, 1 O

[0198] in which Ri denotes H or CH3or C2H5, preferably H or CH3, and R2denotes an alkyl radical having from 10 to 30 carbon atoms and preferably from 12 to 22 carbon atoms, and (c) a crosslinking polymerizable monomer, containing a CH2=C( group with at least one other polymerizable group, the unsaturated bonds of which are not conjugated relative to one another.Acrylates in accordance with the invention comprise, for example, lauryl acrylate, stearyl acrylate, decyl acrylate, isodecyl acrylate and dodecyl acrylate, and the corresponding methacrylates, lauryl methacrylate, stearyl methacrylate, decyl methacrylate, isodecyl methacrylate and dodecyl methacrylate.

[0199] Crosslinking polymerizable monomers of type (c) are, for example, and preferably, polyallyl ethers, such as, in particular, polyallyl sucrose and polyallyl pentaerythritol.

[0200] Crosslinked polymers of this type are well known; they are prepared and described in patents US-3 915 921 and 4 509949.

[0201] According to the invention, use may more particularly be made of (i) those which are constituted of 95% to 60% by weight of acrylic units, of 4% to 40% by weight of acrylate units and of 0.1% to 6% by weight of crosslinking monomer of type (c), or (ii) those which are constituted of 98% to 96% by weight of acrylic units, of 1% to 4% by weight of acrylate units and of 0.1% to 0.6% by weight of crosslinking monomer of type (c).

[0202] Among said crosslinked polymers above, those most particularly preferred according to the present invention are the products sold by the company LUBRIZOL under the trade names Pemulen® TRI, Pemulen® TR2, Carbopol® 1342, and even more preferentially Pemulen® TR2.

[0203] The crosslinked polymer containing acrylic units and Cio-C3oalkyl acrylate units may be present in a content ranging from 0.01% to 3%, and preferably from about 0.05% to 1% by weight relative to the total weight of the composition.

[0204] Aqueous phase

[0205] According to one embodiment, the composition according to the invention may comprise water.

[0206] Advantageously, the water may be present in a content ranging from 10% to 60% by weight, preferably from 20% to 50% by weight, relative to the total weight of the composition.

[0207] Polyol

[0208] The composition according to the invention can comprise a polyol.

[0209] Preferably, the polyol(s) bear:

[0210] - a saturated or unsaturated, linear or branched hydrocarbon-based chain comprising at least two hydroxyl functions; or- a saturated, linear or branched hydrocarbon-based chain in which one or more carbon atoms are replaced with an oxygen atom and which comprises at least two hydroxyl functions, for instance polyethylene glycols (PEGs) containing from 4 to 8 ethylene glycol units.

[0211] Preferably, the polyol(s) bear a saturated, linear or branched hydrocarbon-based chain. Advantageously, the polyol(s) comprise a number of carbon atoms ranging from 2 to 20, preferably from 2 to 10, and comprise from 2 to 12 and better still from 2 to 8 hydroxyl functions.

[0212] The polyol(s) may be chosen from glycols such as ethylene glycol, propylene glycol, propane-1, 3-diol, isoprene glycol, butylene glycol, dipropylene glycol, polypropylene glycol, caprylyl glycol, pentylene glycol, hexylene glycol, glycerol, diglycerol, erythritol, pentaerythritol, arabitol, adonitol, sorbitol, dulcitol, maltitol and panthenol, and mixtures thereof.

[0213] Among these polyols, polyols having from 3 to 8 carbon atoms are preferentially chosen, such as glycerol, caprylyl glycol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, propane-1, 3-diol, and mixtures thereof.

[0214] The polyol may be present in a content ranging from 0.1% to 15% by weight, preferably ranging from 1% to 10% by weight, relative to the total weight of the composition.

[0215] Ci-Cj monoalcohol

[0216] The composition according to the invention may comprise a C2-C4monoalcohol.

[0217] The C2-C4monoalcohol may be chosen from ethanol, isopropanol, n-propanol, tert-butanol, butanol, and mixtures thereof, and preferably ethanol.

[0218] Advantageously, the C2-C4monoalcohol may be present in a content ranging from 2% to 12% by weight, preferably from 5% to 10% by weight, relative to the total weight of the composition.

[0219] Additional adjuvants or additives

[0220] The composition of the present invention may also comprise conventional cosmetic adjuvants or additives, for example fragrances, chelating agents, preserving agents and bactericides, surfactants, thickeners, pH regulators, additional fillers, and mixtures thereof. A person skilled in the art can select the amount of additional adjuvants or additives so as not to adversely affect the end use of the composition according to the present invention.Composition

[0221] The composition of the present invention may be in anhydrous form or in the form of an emulsion, preferably an oil-in-water emulsion.

[0222] Uses and processes

[0223] According to one of its aspects, the present invention relates to the non-therapeutic use of a composition as defined previously in the cosmetic field, in particular for caring for keratin materials, in particular the skin of the face and / or the body, to protect keratin materials, in particular the skin, when exposed to UV radiation.

[0224] According to another of its aspects, the present invention relates to a cosmetic process for caring for keratin materials, in particular the skin, comprising the application to the keratin materials, in particular the topical application to these keratin materials, of a composition as defined in the present invention.

[0225] According to one aspect, the invention also relates to a non-therapeutic cosmetic process for limiting the darkening of the skin and / or improving the color and / or uniformity of the complexion, comprising the application, to the surface of keratin materials, in particular the skin, of at least one cosmetic composition as defined previously.

[0226] The invention also relates to a non-therapeutic cosmetic process for preventing the signs of aging of keratin materials, in particular the skin, comprising the application to the surface of the keratin materials of at least one cosmetic composition as defined previously.

[0227] The cosmetic uses and processes considered according to the invention are non-therapeutic. The cosmetic use or process of the invention is performed by topically administering a composition according to the invention.

[0228] Topical administration involves externally applying cosmetic compositions to the skin according to the usual techniques for the use of these compositions.

[0229] Throughout the description, including the claims, the expressions “between ... and ...” and “ranging from ... to ...” should be understood as meaning limits included, unless otherwise specified.

[0230] The invention is illustrated in greater detail in the examples that follow. The amounts are indicated as weight percentages.Example

[0231] Example 1: Preparation of the compositions

[0232] Composition II according to the invention, comprising the fatty compounds described above and a spherical silica, and compositions Cl to C4 outside the invention, are prepared according to the protocol described below, the nature of the ingredients and the respective amounts thereof are given in table 1. The contents are expressed as weight percentages relative to the total weight of the composition.

[0233] Preparation of compositions II and Cl to C4

[0234]

[0235] In a first step, the compounds of phase Bl are introduced into a device containing a rotor stator. The mixture obtained is heated to 75°C before being left to disperse for at least 15 minutes, until the UV-screening agents are completely melted and solubilized. The heating is then stopped and the compounds of phase B2 are added to the mixture at the temperature of 75°C before being left to disperse until a homogeneous mixture is obtained, the mixture is kept stirring until it is transferred to the production tank.

[0236] In parallel with this first step, the compounds of phase A are introduced together into a production tank equipped with a turbine and scraper blades, the water being hot or cold at the time of introduction, and the mixture is then heated, if necessary, to a temperature of 65°C. The mixture is left to disperse until a homogeneous mixture is obtained, at a temperature of 65°C.

[0237] The mixture obtained during the first step, comprising the compounds of phase Bl and of phase B2, is sucked into the mixture of the compounds of phase A with stirring, then the mixture is left to cool under turbine mixing to a temperature of 38°C, and then under scraper blade mixing alone and under vacuum to a temperature of 35°C. The compounds of phase Cl, then the compounds of phase C2 are sucked into the mixture with stirring using the turbine and scraper blades at a temperature of 35°C. The mixture is left to disperse until a homogeneous mixture is obtained, while being left to cool to a temperature of about 30°C. If necessary, the mixture is then left to cool under scraper blade mixing alone and under vacuum. Finally, phase D is then added under turbine and scraper blade mixing at a temperature of 30°C, then the mixture is left to disperse until a homogeneous mixture is obtained, while maintaining a temperature of 30°C.[Table 1]

[0238] Phase Compounds II Cl C2 C3 C4

[0239] Water qs qs qs qs qs 100 100 100 100 100 Glycerol 3 3 3 3 3 Propanediol 2.5 2.5 2.5 2.5 2.5 Terephthalylidene dicamphor sulfonic

[0240] A 0.32 0.32 0.32 0.32 0.32 acid

[0241] Triethanolamine 0.2 0.2 0.2 0.2 0.2 Trisodium ethylenediamine disuccinate 0.18 0.18 0.18 0.18 0.18 Hydroxy ethyl cellulose (NATROSOL

[0242] 0.05 0.05 0.05 0.05 0.05 250 HHR CS from ASHLAND)

[0243] bis-Ethylhexyloxyphenol

[0244] 4.25 4.25 4.25 4.25 4.25 methoxyphenyl triazine

[0245] Drometrizole trisiloxane 1 1 1 1 1 Dicaprylyl carbonate 5 - 5 - - Butyl methoxydibenzoylmethane 4.5 4.5 4.5 4.5 4.5 Isopropyl myristate 3 17 12 13 12 Ethylhexyl triazone 4.75 4.75 4.75 4.75 4.75 Diisopropyl adipate 4 - - 4 - Bl Behenyl acrylate / 2-hydroxyethyl

[0246] acrylate copolymer (*) 2.5 2.5 2.5 2.5 2.5 C12-C15 alkyl benzoate 2 2 2 2 2 Methoxypropylamino

[0247] cyclohexenylidene 1 1 1 1 1 ethoxy ethylcyanoacetate

[0248] Diethylamino hydroxybenzoyl hexyl

[0249] 2 2 2 2 2 benzoate

[0250] Diisopropyl sebacate 5 - - - 5 Acrylates C10-C30 alkyl acrylate

[0251] crosspolymer (PEMULEN TR-2 0.08 0.08 0.08 0.08 0.08 B2

[0252] POLYMER from LUBRLZOL)

[0253] Tocopherol - - 1 1 1 Citric acid 0.001 0.001 0.001 0.001 0.001 Trisodium ethylenediamine disuccinate 0.0009 0.0009 0.0009 0.0009 0.0009 Cl Pentylene glycol 0.1 0.1 0.1 0.1 0.1

[0254] Tocopherol 1 1 - - Water 0.896 0.896 8.896 8.896 8.896 Silica (SUNSPHERE H 51 from AGO

[0255] 5 5 5 5 5 C2 SI- TECH)

[0256] Perlite 1 1 1 1 1

[0257]

[0258] D Ethanol 7 7 7 7 7(*) the synthesis of the polymer is described in FR3146591 Al in the example of the preparation of polymer 1.

[0259] Example 2: Stability check measurement

[0260] The compositions are prepared and then stored for 2 months at 4°C, at room temperature (25°C) and at 45°C.

[0261] The macroscopic appearance and microscopic appearance of the composition are characterized. The appearance of the composition must remain identical or close to the initial appearance. In particular, the composition must not exhibit any change in color, or the appearance of crystals in the composition.

[0262] The stability check measurements are carried out for each of the compositions II and Cl to C4; the results obtained are given in table 2.

[0263] [Table 2]

[0264] Formulations T = 4°C T = 2°C T = 45°C Macro appearance Micro appearance Macro appearance Macro appearance Compliant: Compliant: Compliant: Smooth II Smooth Compliant Smooth yellow yellow fluid yellow fluid fluid

[0265] Non-compliant: Non-compliant: Compliant: Appearance of Compliant: Smooth fluid with Cl Smooth yellow large UV- Smooth yellow intensification of fluid screening agent fluid the yellow crystals

[0266] Non-compliant: Non-compliant: Non-compliant: Compliant: Appearance of Smooth fluid with Smooth fluid with C2 Smooth large UV- intensification of intensification of yellow fluid screening agent the yellow the yellow crystals

[0267] Non-compliant: Non-compliant: Non-compliant: Compliant: Appearance of Smooth fluid with Smooth fluid with C3 Smooth yellow large UV- intensification of intensification of fluid screening agent the yellow the yellow crystals

[0268] Non-compliant: Non-compliant: Compliant: Appearance of Compliant: Smooth fluid with C4 Smooth yellow large UV- Smooth yellow intensification of fluid screening agent fluid the yellow

[0269]

[0270] crystalsIt appears that composition II according to the invention does not show any change in color or formation of crystals after storing for 2 months at a temperature of 4°C, at room temperature and at a temperature of 45°C; it therefore remains stable.

[0271] On the other hand, by macroscopic and / or microscopic observations of the comparative compositions Cl to C4, it is concluded that the appearance of these compositions changed after storing for 2 months at a temperature of 4°C, at room temperature and at a temperature of 45°C. Consequently, compositions Cl to C4 are not stable.

[0272] Example 3: Tackiness measurement

[0273] The tackiness of the various compositions II and Cl to C4 was measured according to the protocol described below; the results obtained are given in table 3.

[0274] Protocol for testing the tackiness

[0275] The protocol for testing the tackiness of a composition is as follows. A tub of 250 g of sand is prepared, then a black Supplale with dimensions of 90 mm by 60 mm (Supplale 100x75mm - black from SOUDOTIQUE PG SAR) is left for 15 minutes on a hotplate at 35°C.

[0276] An amount of 100 pL of the composition to be tested is then applied by spreading the composition toward the upper half of the Supplale, then downward, then upward again and toward the right twice, without going to the edge. The Supplale is then left on the hotplate for 5 minutes before being weighed and taring the balance. The side of the Supplale containing the composition is pressed for 3 seconds in the sand, and the excess sand is removed by tapping 3 times in an empty tub.

[0277] Finally, the Supplale with the sand is weighed. It should be noted that the higher the weight obtained, the more tacky the composition.

[0278] [Table 3]

[0279] Composition Weight of sand

[0280] II 0.63 g

[0281] Cl 0.44 g

[0282] C2 0.80 g

[0283] C3 0.47 g

[0284]

[0285] C4 0.55 gThe results depicted above show that only composition II of the invention is stable and exhibits satisfactory tackiness.

[0286] The composition II according to the invention is in the form of a fluid oil-in-water emulsion. The composition applied to the skin spreads easily and forms a homogeneous, adherent but non-tacky film, thus conferring effective sun protection on the entire surface of the skin.

[0287] Example 4:

[0288] Composition C5 outside of the invention is prepared according to the protocol described above. The nature of the ingredients and their respective amounts are given in table 4. [Table 4]

[0289] Phase Compounds C5

[0290] Water qs 100 Glycerol 3 Propanediol 2.5 Terephthalylidene dicamphor sulfonic acid 0.32

[0291] A

[0292] Triethanolamine 0.2 Trisodium ethylenediamine disuccinate 0.18 Hydroxyethyl cellulose

[0293] 0.05 (NATROSOL 250 HHR CS from ASHLAND)

[0294] bis-Ethylhexyloxyphenol methoxyphenyl triazine 4.25

[0295] Drometrizole trisiloxane 1 Dicaprylyl carbonate 5 Butyl methoxy dibenzoylmethane 4.5 Isopropyl myristate 3 Ethylhexyl tri azone 4.75

[0296] Bl Diisopropyl adipate 4

[0297] Behenyl acrylate / 2-hydroxyethyl acrylate copolymer (*) 2.5

[0298] C12-C15 alkyl benzoate 2 Methoxypropyl amino cyclohexenylidene

[0299] 1 ethoxy ethylcyanoacetate

[0300] Diethylamino hydroxybenzoyl hexyl benzoate 2

[0301] Diisopropyl sebacate 5 Acrylates C10-C30 alkyl acrylate crosspolymer

[0302] B2 0.08

[0303] (PEMULEN TR-2 POLYMER from LUBRIZOE)

[0304] Citric acid 0.001 Trisodium ethylenediamine disuccinate 0.0009 Cl Pentylene glycol 0.1

[0305] Tocopherol 1 Water 0.896 Hydrophilic fumed silica (AEROSIL 200 from

[0306] 5

[0307] C2 EVONIK)

[0308]

[0309] Perlite 1

[0310]

[0311] D Ethanol | 7 | (*) the synthesis of the polymer is described in FR3146591 Al in the example of the preparation of polymer 1.

[0312] Stability check measurement

[0313] Composition C5, similar to composition II according to the invention, with the spherical amorphous silica being replaced by a hydrophilic fumed silica, does not make it possible to obtain an emulsion. The composition phase separates.

Claims

1. Claims1. A composition, preferably a cosmetic or dermatological composition, in particular for caring for keratin materials, preferably for caring for the skin, comprising: - at least one UV-screening agent;- dicaprylyl carbonate;- diisopropyl adipate;- diisopropyl sebacate; and- a spherical amorphous silica.

2. The composition as claimed in claim 1, wherein said UV-screening agent is chosen from organic UV-screening agents, preferably from lipophilic organic UV-screening agents and / or hydrophilic organic UV-screening agents.

3. The composition as claimed in claim 1 or 2, wherein said UV-screening agent is chosen from dibenzoylmethane compounds, benzophenone compounds, phenylbenzotriazole compounds, triazine compounds, merocyanine compounds, benzene-l,4-di(3 -methylidene- 10-camphorsulfonic) acid and mixtures thereof, and preferably from butyl methoxydibenzoylmethane, diethylamino hydroxybenzoyl hexyl benzoate, drometrizole trisiloxane, bis-ethylhexyloxyphenol methoxyphenyl triazine, ethylhexyl triazone, methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate (INCI name), and also the 2E geometric isomers thereof, benzene- l,4-di(3 -methylidene- 10-camphorsulfonic) acid and mixtures thereof.

4. The composition as claimed in any one of the preceding claims, wherein said UV-screening agent is present in a content ranging from 5% to 35% by weight, preferably from 7% to 30% by weight, and more preferentially from 10% to 25% by weight, relative to the total weight of the composition.

5. The composition as claimed in any one of the preceding claims, wherein the dicaprylyl carbonate is present in a content ranging from 2% to 8% by weight, preferably from 4% to 6% by weight, relative to the total weight of the composition, the diisopropyl adipate is present in a content ranging from 2% to 7% by weight, preferably from 3% to 5% by weight relative to the total weight of the composition and the diisopropyl sebacate is present in a content ranging from 2% to 8% by weight, preferably from 4% to 6% by weight relative to the total weight of the composition.

6. The composition as claimed in any one of the preceding claims, comprising an additional oil chosen from isopropyl myristate, isopropyl palmitate, isononyl isononanoate, alkyl benzoates having between 12 and 15 carbon atoms, caprylic / capric triglycerides, ethylhexyl hydroxystearate, and mixtures thereof.

7. The composition as claimed in any one of the preceding claims, comprising isopropyl myristate, in particular in a content ranging from 1% to 10% by weight, preferably ranging from 2% to 5% by weight, relative to the total weight of the composition.

8. The composition as claimed in any one of the preceding claims, comprising alkyl benzoates having between 12 and 15 carbon atoms, in particular in a content ranging from 0.5% to 5% by weight, preferably ranging from 1% to 3% by weight relative to the total weight of the composition.

9. The composition as claimed in any one of the preceding claims, wherein the spherical amorphous silica is present in a content ranging from 1% to 10% by weight, preferably ranging from 2% to 8% by weight, more preferentially ranging from 3% to 7% by weight, relative to the total weight of the composition.

10. The composition as claimed in any one of the preceding claims, comprising a lipophilic polymer prepared by polymerizing the monomer of formula CH2=CH-COO- Ri and 2 -hydroxy ethyl acrylate, Ri being chosen from Ci6-C22 alkyl radicals, and preferably being the behenyl radical.

11. The composition as claimed in any one of the preceding claims, comprising at least one polyol having from 3 to 8 carbon atoms, preferably chosen from glycerol, caprylyl glycol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, propane-1, 3-diol, and mixtures thereof.

12. The composition as claimed in claim 11, comprising a polyol content ranging from 0.1% to 15% by weight, preferably ranging from l%to 10% by weight, relative to the total weight of the composition.

13. The composition as claimed in any one of the preceding claims, comprising at least one C2-C4monoalcohol, preferably ethanol.

Images